Minako Tomiita

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.

Multicentre, prospective, single-arm, non-controlled, open-label trial to evaluate the safety and efficacy of live attenuated influenza vaccine in paediatric patients with atopic dermatitis undergoing dupilumab therapy: a protocol.

Journal: BMJ open

Published: August 03, 2025

Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.

Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.

Journal: Pediatric rheumatology online journal

Published: June 19, 2025

Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits.

Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits.

Journal: Pediatric rheumatology online journal

Published: April 18, 2025

Early-onset enterocolitis and concerning for macrophage activation syndrome in NLRC4 p.Val342Ala: IL-18 insights.

Early-onset enterocolitis and concerning for macrophage activation syndrome in NLRC4 p.Val342Ala: IL-18 insights.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: February 28, 2025

Nationwide epidemiological survey of primary Sjogren's disease in Japan using the National Database of Designated Intractable Diseases.

Nationwide epidemiological survey of primary Sjogren's disease in Japan using the National Database of Designated Intractable Diseases.

Journal: Modern rheumatology

Published: January 21, 2025

In-Depth Proteomic Profiles Prior to Symptom Development in Food Protein-Induced Enterocolitis.

In-Depth Proteomic Profiles Prior to Symptom Development in Food Protein-Induced Enterocolitis.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: October 24, 2024

Eosinophil ETosis and Charcot-Leyden crystals in Kimura disease.

Eosinophil ETosis and Charcot-Leyden crystals in Kimura disease.

Journal: The journal of allergy and clinical immunology. Global

Published: June 28, 2024

AUTOIMMUNE DISEASES IN PEDIATRIC AGE UP-TO-DATE

AUTOIMMUNE DISEASES IN PEDIATRIC AGE UP-TO-DATE

Journal: Arerugi = [Allergy]

Published: November 15, 2023

A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide.

A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide.

Journal: Rheumatology (Oxford, England)

Published: October 23, 2022

Risk Factors for Lung Function Decline in Pediatric Asthma under Treatment: A Retrospective, Multicenter, Observational Study.

Risk Factors for Lung Function Decline in Pediatric Asthma under Treatment: A Retrospective, Multicenter, Observational Study.

Journal: Children (Basel, Switzerland)

Published: August 08, 2022

Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan.

Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan.

Journal: Modern rheumatology

Published: July 05, 2022

Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study.

Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study.

Journal: Modern rheumatology

Published: May 11, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026